4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-041469
Options or other derivatives
- Chief Executive Officer acquired 192,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…